Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
American Woodmark | AMWD | Nov 22, 2024 | 97.24 | +2.64 |
Americas Car-Mart | CRMT | Nov 22, 2024 | 44.87 | +4.18 |
Americas Gold And Silver | USAS | Nov 22, 2024 | 0.38 | -0.18 |
Americold Realty Trust | COLD | Nov 22, 2024 | 23.09 | +0.92 |
Ameriprise Financial | AMP | Nov 22, 2024 | 572.07 | +0.33 |
Ameris Bancorp | ABCB | Nov 22, 2024 | 71.79 | +2.94 |
Amerisafe | AMSF | Nov 22, 2024 | 58.69 | +1.07 |
AmeriServ Financial | ASRV | Nov 22, 2024 | 2.88 | -5.26 |
Ames National | ATLO | Nov 22, 2024 | 17.62 | -0.65 |
Amesite | AMST | Nov 22, 2024 | 2.42 | +2.54 |
Ametek | AME | Nov 22, 2024 | 197.38 | +0.83 |
Amgen | AMGN | Nov 22, 2024 | 294.53 | +1.60 |
Amicus Therapeutics | FOLD | Nov 22, 2024 | 9.66 | +1.68 |
Amkor Technology | AMKR | Nov 22, 2024 | 26.54 | +0.72 |
AMMO | POWW | Nov 22, 2024 | 1.28 | +1.59 |
AMMO A Pref | POWWP | Nov 22, 2024 | 21.02 | -4.44 |
AMN Healthcare Services | AMN | Nov 22, 2024 | 25.84 | +0.54 |
Amneal Pharmaceuticals A | AMRX | Nov 22, 2024 | 8.39 | +0.84 |
Ampco-Pittsburgh | AP | Nov 22, 2024 | 1.73 | -1.14 |
Amphastar Pharmaceuticals | AMPH | Nov 22, 2024 | 45.46 | +2.04 |
Amphenol | APH | Nov 22, 2024 | 74.29 | +1.43 |
Amplify Energy | AMPY | Nov 22, 2024 | 6.93 | +2.36 |
Amplify Online Retail ETF | IBUY | Nov 22, 2024 | 66.48 | +1.73 |
Amplify Transformational Data Sharing ETF | BLOK | Nov 22, 2024 | 50.39 | +4.07 |
Amplitech Group | AMPG | Nov 22, 2024 | 1.24 | +46.05 |
Amplitude A | AMPL | Nov 22, 2024 | 10.73 | +2.43 |
Amprius Technologies | AMPX | Nov 22, 2024 | 1.94 | -2.02 |
AMREP | AXR | Nov 22, 2024 | 37.20 | +0.92 |
AMTD Digital ADR | HKD | Nov 22, 2024 | 2.98 | -0.67 |
AMTD Idea Group ADR | AMTD | Nov 22, 2024 | 1.26 | +5.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.